Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
February 04 2021 - 8:30AM
Business Wire
Cerus Corporation (Nasdaq: CERS) announced today that William
‘Obi’ Greenman, Cerus’ president and chief executive officer, and
Kevin D. Green, Cerus’ chief financial officer, are scheduled to
participate in two conferences:
- BTIG Virtual MedTech, Digital Health, Life Science &
Diagnostic Tools Conference on Wednesday, February 17th at 1:30
P.M. ET.
- The Cowen 41st Annual Health Care Conference on Monday, March
1st at 2:40 P.M. ET.
A live webcast of the events will be available on the Investor
Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be
available for approximately two weeks following the completion of
the event.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the
world’s blood supply and aims to become the preeminent global blood
products company. Headquartered in Concord, California, the company
develops and supplies vital technologies and pathogen-protected
blood components to blood centers, hospitals, and ultimately
patients who rely on safe blood. The INTERCEPT Blood System for
platelets and plasma is available globally and remains the only
pathogen reduction system with both CE mark and FDA approval for
these two blood components. The INTERCEPT red blood cell system is
under regulatory review in Europe, and in late-stage clinical
development in the US. Also in the US, the INTERCEPT Blood System
for Cryoprecipitation is approved for production of Pathogen
Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product
for the treatment and control of bleeding, including massive
hemorrhage, associated with fibrinogen deficiency. For more
information about Cerus, visit www.cerus.com and follow us on
LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210204005306/en/
Matt Notarianni – Senior Director, Investor Relations Cerus
Corporation 925-288-6137
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Sep 2023 to Sep 2024